TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07688239: The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Sponsor: Tiziana Life Sciences LTD · Phase: PHASE2 · Area: RARE_ORPHAN · Target Enrollment: 44 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$14,008,000

Rescue Site Savings

+$9,270,000

Unlock Full NCT07688239 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07688239 Rescue Dossier →